Clinical Review

Evaluation of Clonidine and Prazosin for the Treatment of Nighttime Posttraumatic Stress Disorder Symptoms

Author and Disclosure Information

 

References

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

Pages

Recommended Reading

Attention-Deficit/Hyperactivity Disorder in a VA Polytrauma Clinic
Federal Practitioner
Decrease of Sexual Violence on Military Campuses Is Not Enough
Federal Practitioner
Depression and Substance Abuse Intensify Suicide Risk
Federal Practitioner
Management of Comorbid Sleep Disorders in Patients With PTSD
Federal Practitioner
PTSD Campaign: Caring and Sharing
Federal Practitioner
VA Hospital Deficiencies Contributed to Marine’s Death
Federal Practitioner
Banking on Vets for Better PTSD Research
Federal Practitioner
Female Service Members in the Long War
Federal Practitioner
Yoga-Based Classes for Veterans With Severe Mental Illness: Development, Dissemination, and Assessment
Federal Practitioner
PTSD in Women and Men
Federal Practitioner

Related Articles